Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 78
Filtrar
1.
Emerg Med J ; 26(7): 492-6, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19546269

RESUMO

BACKGROUND: Biphasic waveform defibrillation results in higher rates of termination of fibrillation than monophasic waveform defibrillation but has not been shown to improve survival outcomes. OBJECTIVE: To compare the effectiveness of a biphasic automated external defibrillator (AED) with a monophasic AED for witnessed out-of-hospital cardiac arrest (OHCA) due to ventricular fibrillation (VF). METHODS: In a prospective population-based cohort study, adults with witnessed VF OHCA were treated with either monophasic or biphasic waveform AED shocks. The primary outcome measure was neurologically favourable 1-month survival, defined as a Cerebral Performance Categories score of 1 or 2. RESULTS: Of 366 adults with witnessed OHCA of presumed cardiac aetiology, 74 (20%) had VF. Termination of VF with the first shock tended to occur more frequently after biphasic AED shocks (36/44 (82%) vs 20/30 (67%), p = 0.14). Return of spontaneous circulation (ROSC) occurred more frequently after biphasic AED shocks (29/44 (66%) vs 8/30 (27%), p = 0.001). Neurologically favourable 1-month survival was also more frequent in the biphasic group (10/44 (23%) vs 1/30 (3%), p = 0.04). The median time interval from the first shock to the second shock was 67 s in the monophasic group and 24 s in the biphasic group (p = 0.001). CONCLUSIONS: Treatment with biphasic AED shocks improved the likelihood of ROSC and neurologically favourable 1-month survival after witnessed VF compared with monophasic AED shocks. In addition to waveform differences, a shorter time interval from the first shock to the second shock could account for the better outcomes with biphasic AED.


Assuntos
Desfibriladores , Cardioversão Elétrica/estatística & dados numéricos , Serviços Médicos de Emergência , Parada Cardíaca/terapia , Doenças do Sistema Nervoso/etiologia , Fibrilação Ventricular/terapia , Adulto , Idoso , Reanimação Cardiopulmonar/estatística & dados numéricos , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Resultado do Tratamento
2.
Eur J Emerg Med ; 9(1): 67-70, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11989502

RESUMO

A 24-year-old Japanese man was admitted because of massive haematemesis and melaena with persistent abdominal pain. Markedly bloody ascites and severely oedematous small intestine were recognized, and angiography then revealed superior mesenteric vein thrombosis. After resection of the necrotic small intestine, continuous intravenous infusion of heparin and urokinase was performed. This patient had no familial or personal history of thrombosis. On the 15th day after operation, an initial search for lupus anticoagulant revealed that the prothrombin time (PT) ratio and dilute activated partial thromboplastin time (aPTT) were positive under heparin treatment, without evidence of rheumatic or connective tissue disease. Thrombocytopenia was observed with a nearly normocellular bone marrow. A follow-up examination 1 year later still revealed an increased aPTT. However, all tests for antiphospholipid antibodies had been negative including dilute aPTT for about 2 years since the 15th day after operation. These findings suggest that, in this patient, superior mesenteric vein thrombosis has not been associated with primary antiphospholipid syndrome but is probably idiopathic. Positive tests for lupus anticoagulant in the initial period may be unreliable due to heparin treatment.


Assuntos
Anticoagulantes/uso terapêutico , Síndrome Antifosfolipídica/diagnóstico , Heparina/uso terapêutico , Inibidor de Coagulação do Lúpus/sangue , Oclusão Vascular Mesentérica/etiologia , Trombose/etiologia , Adulto , Anticorpos Antifosfolipídeos/análise , Reações Falso-Positivas , Humanos , Masculino , Oclusão Vascular Mesentérica/tratamento farmacológico , Oclusão Vascular Mesentérica/imunologia , Oclusão Vascular Mesentérica/cirurgia , Terapia Trombolítica , Trombose/tratamento farmacológico , Trombose/imunologia , Trombose/cirurgia
3.
Ann Acad Med Singap ; 30(5): 528-31, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11603140

RESUMO

INTRODUCTION: Because the use of procalcitonin (PCT) as a marker of bacterial infection has been advocated, this study was carried out to determine the usefulness of plasma PCT in the early diagnosis and differentiation of patients with non-infectious systemic inflammatory response syndrome (SIRS) from those with sepsis, and the relationship between plasma PCT level and severity of organ failure. MATERIALS AND METHODS: Thirty-five patients with non-septic SIRS (n = 16), sepsis (n = 7) or septic shock (n = 12) were included in this study. PCT and C-reactive protein (CRP) levels were measured and sepsis-related organ failure assessment (SOFA) score was calculated for these patients. Plasma PCT was measured by immunoluminometric assay. RESULTS: The median (minimum, maximum) plasma PCT levels were 0.6 (0.1, 3.4) ng/mL in non-septic SIRS, 5.4 (0.9, 47.7) ng/mL in sepsis and 73.4 (9.6, 824.1) ng/mL in septic shock, and significant differences existed in plasma PCT levels among the three groups. The median (minimum, maximum) CRP levels were 13.8 (0.3, 48.8) mg/dL in non-septic SIRS, 23.3 (1.4, 26.6) mg/dL in sepsis and 17.4 (2.2, 34.1) mg/dL in septic shock, without significant differences among the three groups. A good correlation was found between plasma PCT level and SOFA score (rs = 0.766, P < 0.0001), although no correlation was found between CRP level and SOFA score. CONCLUSIONS: CRP is increased by inflammatory disease as well as infection and is therefore not a good indicator of infection in patients with severe SIRS. On the other hand, PCT is a good indicator of severity of sepsis and organ failure in patients with severe SIRS since PCT levels correlated with sepsis and SOFA scores. PCT level is useful for diagnosis of sepsis and as an indicator of severity of organ failure in patients with SIRS.


Assuntos
Calcitonina/sangue , Glicoproteínas/sangue , Insuficiência de Múltiplos Órgãos/diagnóstico , Precursores de Proteínas/sangue , Síndrome de Resposta Inflamatória Sistêmica/diagnóstico , Análise de Variância , Biomarcadores/sangue , Proteína C-Reativa/análise , Peptídeo Relacionado com Gene de Calcitonina , Feminino , Humanos , Imunoensaio , Masculino , Pessoa de Meia-Idade , Insuficiência de Múltiplos Órgãos/sangue , Índice de Gravidade de Doença , Síndrome de Resposta Inflamatória Sistêmica/sangue , Síndrome de Resposta Inflamatória Sistêmica/mortalidade
7.
Masui ; 48(9): 981-5, 1999 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-10513173

RESUMO

The agreement between scores for observer-reported face scale (FS) and the self-reported visual analog scale (VAS) in postoperative pain assessment has not been compared for different types of surgery and for different times in the postoperative course. Five grade FS (1-5) judged by a nurse was compared with VAS (0-100 mm) reported by patients who had undergone hepatectomy (group H, n = 60) or esophageal cancer surgery by a thoracoabdominal procedure (group E, n = 50). Postoperative analgesia was mainly achieved by epidural morphine administration combined with lidocaine or bupivacaine in both groups. Pain measurement was performed at admission to the ICU, 1, 2, 6, and 10 hours later, and the following morning in group H, and 0.5, 1, 2, 6, 10, and 14 hours after tracheal extubation in group E. VAS scores (means +/- SD) were respectively 46 +/- 29 and 31 +/- 25 at ICU admission and one hour later in group H, and 41 +/- 36 and 36 +/- 33 thirty minutes and one hour after tracheal extubation in group E. FS values (means +/- SD) were respectively 2.6 +/- 1.2 and 2.1 +/- 1.1 at ICU admission and one hour later in group H, and 2.4 +/- 1.3 and 2.2 +/- 1.2 thirty minutes and one hour after tracheal extubation in group E. VAS and FS decreased in both groups over time postoperatively. A fair degree of agreement was found between VAS and FS scores in group H at ICU admission and one hour later (weighted kappa values = 0.29 and 0.28, respectively); on the other hand, good agreement between these two scores was found in group E thirty minutes and one hour after tracheal extubation (weighted kappa values = 0.67 and 0.62, respectively). Weighted kappa values decreased thereafter in group E, but did not change in group H over the postoperative course. We conclude that postoperative pain assessment based on facial expression is more useful early after extubation for patients who have undergone esophagectomy than for those who have undergone hepatectomy.


Assuntos
Esofagectomia , Hepatectomia , Medição da Dor/métodos , Dor Pós-Operatória/diagnóstico , Idoso , Feminino , Humanos , Intubação Intratraqueal , Masculino , Pessoa de Meia-Idade , Variações Dependentes do Observador , Fatores de Tempo
8.
Eur J Emerg Med ; 6(2): 161-4, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10461563

RESUMO

A 55-year-old man developed acute respiratory failure, pulmonary hypertension and left heart failure due to acute myocardial infarction. Nitric oxide (NO) inhalation improved arterial oxygenation, decreased pulmonary arterial pressure and increased cardiac output (CO), but combined use of dobutamine with NO produced increases in pulmonary arterial pressure and pulmonary capillary wedge pressure (PCWP). In this patient, amrinone decreased pulmonary arterial pressure and PCWP, and increased PaO2/FiO2 effectively while increasing CO. Combined use of inhaled NO and intravenous amrinone may have beneficial effects for a patient with acute respiratory and cardiac failure.


Assuntos
Amrinona/administração & dosagem , Cardiotônicos/administração & dosagem , Insuficiência Cardíaca/tratamento farmacológico , Infarto do Miocárdio/complicações , Óxido Nítrico/administração & dosagem , Insuficiência Respiratória/tratamento farmacológico , Vasodilatadores/administração & dosagem , Doença Aguda , Quimioterapia Combinada , Insuficiência Cardíaca/etiologia , Hemodinâmica/efeitos dos fármacos , Humanos , Hipertensão Pulmonar/etiologia , Masculino , Pessoa de Meia-Idade , Troca Gasosa Pulmonar/efeitos dos fármacos , Respiração Artificial , Insuficiência Respiratória/etiologia
9.
Eur J Emerg Med ; 6(1): 77-9, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10340740

RESUMO

Clonidine, an alpha2 agonist, was administered through a nasogastric tube for the treatment of hypertension in a head-injury patient with elevated plasma catecholamines. Haemodynamic parameters were stabilized with a reduction in sympathetic nervous activity. The plasma clonidine concentration, measured by radioimmunoassay, rapidly increased following the administration. After cessation of oral administration of clonidine, mean arterial blood pressure gradually increased. So clonidine was again administered orally and good blood pressure control was achieved and no change in consciousness level was observed. Oral clonidine was useful and effective for hypertension in this head injury patient.


Assuntos
Agonistas alfa-Adrenérgicos/administração & dosagem , Clonidina/administração & dosagem , Traumatismos Craniocerebrais/complicações , Hipertensão/tratamento farmacológico , Administração Oral , Idoso , Humanos , Hipertensão/etiologia , Intubação Gastrointestinal , Masculino , Resultado do Tratamento
10.
Am J Emerg Med ; 17(2): 203-6, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10102328

RESUMO

The purpose of this study was to evaluate a colorimetric end-tidal CO2 (ETCO2) detector (EASY CAP) as a monitor during prehospital cardiopulmonary resuscitation (CPR) without tracheal intubation. This detector was used for 121 patients during CPR with a laryngeal mask airway or face mask by authorized emergency lifesaving technicians. At 7 to 15 minutes after the initiation of CPR, ETCO was <0.5% in 30 cases (group A), 0.5% to 2.0% in 46 cases (group B) and >2.0% in 45 cases (group C). The rate of return of spontaneous circulation was 17% in group A, 24% in group B, and 48% in group C (groups A v C, P < .01). There was a significant difference in the rate of hospital admission between groups A and C. The ETCO2 value may be useful for monitoring during prehospital CPR with a laryngeal mask airway or face mask.


Assuntos
Capnografia/instrumentação , Reanimação Cardiopulmonar/instrumentação , Colorimetria/instrumentação , Monitorização Fisiológica/instrumentação , Volume de Ventilação Pulmonar , Adulto , Idoso , Serviços Médicos de Emergência , Feminino , Humanos , Japão , Máscaras Laríngeas , Masculino , Máscaras , Pessoa de Meia-Idade , Admissão do Paciente , Estudos Prospectivos
11.
Osaka City Med J ; 45(2): 129-38, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10730079

RESUMO

This study was undertaken to determine whether preoperative epidural morphine using double-catheter technique would improve postoperative analgesia in patients undergoing esophagectomy with or without continuous intraoperative epidural lidocaine in a randomized double-blind and controlled manner. Thirty patients undergoing esophagectomy for esophageal cancer received preoperative epidural morphine 2 mg at T 6-7 and 2 mg at L 3-4 through the catheters, respectively. Thereafter, continuous thoracic epidural infusion of either 1% lidocaine (lidocaine group, n = 15) or normal saline solution (control group, n = 15) at 6 ml/h was initiated. After surgery, mean verbal rating scale of pain (0 to 10) at rest was maintained below 4 and pain on deep breathing was maintained mild in all patients in both groups. There was no significant difference in these values between the groups. In conclusion, preoperative epidural morphine using double-catheter technique provided adequate analgesia following esophagectomy. The addition of intraoperative continuous epidural lidocaine did not improve analgesia.


Assuntos
Analgesia Epidural/instrumentação , Analgésicos Opioides/administração & dosagem , Esofagectomia , Morfina/administração & dosagem , Cuidados Pré-Operatórios , Idoso , Analgésicos Opioides/uso terapêutico , Anestésicos Locais/administração & dosagem , Anestésicos Locais/uso terapêutico , Cateterismo , Método Duplo-Cego , Feminino , Humanos , Cuidados Intraoperatórios , Lidocaína/administração & dosagem , Lidocaína/uso terapêutico , Masculino , Pessoa de Meia-Idade , Morfina/uso terapêutico , Dor Pós-Operatória/tratamento farmacológico
12.
Biochim Biophys Acta ; 1442(2-3): 161-9, 1998 Nov 08.
Artigo em Inglês | MEDLINE | ID: mdl-9804939

RESUMO

Alternative oxidase (AOX) is dramatically induced when the fungus Magnaporthe grisea is incubated with the fungicide SSF-126, which interacts with the cytochrome bc1 complex in the electron transport system of mitochondria. A full-length cDNA for the alternative oxidase gene (AOX) was obtained, and the deduced amino acid sequence revealed marked similarity to other AOXs, but lacks two cysteine residues at corresponding sites which are conserved in plant AOXs and play essential roles in the post-translational regulation. Northern blot experiments showed that treatment of M. grisea cells with SSF-126 induces accumulation of AOX mRNA in a dose-dependent manner, and the level was correlated with the activity of alternative respiration. H2O2 also induced the accumulation of the transcript with a short half-life (<15 min). Nuclear run-on experiments showed that the AOX gene was transcribed constitutively in unstimulated cells. Cycloheximide did not change the basal level of transcription, but induced the accumulation of the transcript, indicating that active degradation of the transcript occurs by factor(s) sensitive to cycloheximide. On the other hand, SSF-126 enhanced the transcriptional activity of AOX gene threefold compared to that of control cells, and H2O2 was also potent for enhancement of the transcription. From these results, it is concluded that the respiratory inhibitor-dependent activation of the transcription is a primary determinant for the induction of alternative respiration in M. grisea. Because we have previously shown that SSF-126 treatment of M. grisea mitochondria induced the generation of superoxide, active oxygen species are thought to be signal mediators to activate AOX gene transcription in M. grisea.


Assuntos
Fungicidas Industriais/farmacologia , Regulação Fúngica da Expressão Gênica/efeitos dos fármacos , Peróxido de Hidrogênio/farmacologia , Magnaporthe/genética , Oxirredutases/genética , Ativação Transcricional , Sequência de Aminoácidos , Arabidopsis/enzimologia , Clonagem Molecular , Sequência Conservada , Cicloeximida/farmacologia , Transporte de Elétrons/efeitos dos fármacos , Complexo III da Cadeia de Transporte de Elétrons/efeitos dos fármacos , Complexo III da Cadeia de Transporte de Elétrons/metabolismo , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Magnaporthe/efeitos dos fármacos , Magnaporthe/enzimologia , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Proteínas Mitocondriais , Dados de Sequência Molecular , Oxirredutases/biossíntese , Consumo de Oxigênio , Proteínas de Plantas , Reação em Cadeia da Polimerase , Biossíntese de Proteínas , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Ativação Transcricional/efeitos dos fármacos
13.
J Clin Anesth ; 10(6): 514-7, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9793819

RESUMO

Clonidine has both analgesic and sedative actions, and it has been used in a variety of settings as a sedative, or both. We administered oral clonidine with intravenous ketamine to a burn patient to control severe pain. Clonidine produced good analgesia and sedation. In addition, clonidine counterbalanced the sympathetic stimulation of ketamine by virtue of its action in reducing sympathetic outflow. The combination of these two drugs may be useful for burn patients with hypertension or myocardial ischemia.


Assuntos
Analgésicos/uso terapêutico , Queimaduras/tratamento farmacológico , Clonidina/uso terapêutico , Hipnóticos e Sedativos/uso terapêutico , Administração Oral , Queimaduras/fisiopatologia , Clonidina/administração & dosagem , Humanos , Ketamina/uso terapêutico , Masculino , Pessoa de Meia-Idade
14.
Acta Anaesthesiol Scand ; 42(6): 713-6, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9689279

RESUMO

BACKGROUND: It has been reported that large amounts of nitric oxide (NO) are released in patients with sepsis. NO is converted to methemoglobin and nitrate. This study was designed to determine whether blood methemoglobin levels were increased in patients with sepsis or septic shock. METHODS: Forty-five critically ill patients including 8 with sepsis but without shock, 6 with septic shock and 31 non-septic patients were enrolled in the study. For septic and septic shock patients, blood methemoglobin concentrations were measured during sepsis or septic shock and at the time of recovery or just before the onset of sepsis. For the remaining non-septic patients, methemoglobin concentrations were measured at ICU admission and discharge. RESULTS: Blood methemoglobin levels in the presence of sepsis or septic shock were significantly (P < 0.05) higher than those in non-septic patients and those at recovery or just before the onset of sepsis in both septic and septic shock patients. CONCLUSIONS: Blood methemoglobin concentration may be useful as a marker of the onset of sepsis or septic shock.


Assuntos
Metemoglobinemia/complicações , Sepse/sangue , APACHE , Contagem de Células Sanguíneas , Pressão Sanguínea , Feminino , Frequência Cardíaca , Humanos , Masculino , Pessoa de Meia-Idade , Sepse/fisiopatologia , Choque Séptico/sangue
15.
Anesth Analg ; 86(6): 1194-200, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9620502

RESUMO

UNLABELLED: In this study, we aimed to elucidate the effects of intrinsic nitric oxide (NO) on cardiac neural regulation. Twenty-two cats were anesthetized with 1.5% isoflurane and allocated to Group I (intact; n = 7), Group D (denervated baroreceptors and vagi; n = 8), or Group B (autonomic blockade with i.v. hexamethonium, propranolol, and atropine; n = 7). Cardiac sympathetic nerve activity (CSNA), mean arterial pressure (MAP), sinus heart rate (HR), and A-H and H-V intervals during pacing (150 bpm) were measured before and after i.v. administration of a NO synthase inhibitor, NG-nitro-L-arginine (L-NNA, 30 mg/kg) and after reversal with an excessive dose of L-arginine (300 mg/kg), before and during intermittent electrical stimulation of the posterior hypothalamus. L-NNA significantly increased MAP in Groups I and B, but not in Group D. L-NNA significantly decreased HR and lengthened A-H in Group I, but not in other groups. L-arginine further decreased HR and lengthened A-H unexpectedly. The reasons for these findings could not be determined in this study. L-NNA did not change CSNA. Hypothalamic stimulation did not potentiate L-NNA-induced changes in CSNA, hemodynamic variables, and atrioventricular conduction. In conclusion, intrinsic NO may modulate atrioventricular conduction and sinus rate through a vagal cholinergic, rather than a nonautonomic mechanism. IMPLICATIONS: Elucidating the roles of intrinsic nitric oxide (NO) on cardiac neural regulation is important. In intact, vagotomized, and baroreceptor-denervated or pharmacologically autonomic blockaded cats, an NO synthesis inhibitor was administered, and atrioventricular conduction and cardiac sympathetic neural discharge were measured. The results suggest a vagal cholinergic mechanism of intrinsic NO.


Assuntos
Nó Atrioventricular/fisiologia , Óxido Nítrico/fisiologia , Anestésicos Inalatórios/administração & dosagem , Animais , Arginina/farmacologia , Nó Atrioventricular/efeitos dos fármacos , Atropina/administração & dosagem , Sistema Nervoso Autônomo/efeitos dos fármacos , Pressão Sanguínea/efeitos dos fármacos , Fascículo Atrioventricular/efeitos dos fármacos , Fascículo Atrioventricular/fisiologia , Estimulação Cardíaca Artificial , Gatos , Fibras Colinérgicas/fisiologia , Estimulação Elétrica , Inibidores Enzimáticos/farmacologia , Bloqueadores Ganglionares/administração & dosagem , Frequência Cardíaca/efeitos dos fármacos , Hexametônio/administração & dosagem , Hipotálamo/fisiologia , Isoflurano/administração & dosagem , Bloqueio Nervoso , Óxido Nítrico/antagonistas & inibidores , Óxido Nítrico Sintase/antagonistas & inibidores , Nitroarginina/farmacologia , Parassimpatolíticos/administração & dosagem , Pressorreceptores/fisiologia , Propranolol/administração & dosagem , Sistema Nervoso Simpático/efeitos dos fármacos , Simpatolíticos/administração & dosagem , Nervo Vago/fisiologia
16.
Anesthesiology ; 88(6): 1558-65, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9637650

RESUMO

BACKGROUND: Epidural morphine yields postoperative pain relief and hemodynamic stability. However, the effects of epidural morphine on sympathetic tone are unclear. This study was designed to elucidate the effects of epidural morphine on cardiac (CSNA) and renal (RSNA) sympathetic nerve activity by direct measurement in anesthetized cats. METHODS: Thirty mongrel cats anesthetized with alpha-chloralose were randomly assigned to one of the following five groups: control (0.2 ml/kg thoracic epidural normal saline; n=5); thoracic epidural morphine (n=9); lumbar epidural morphine (n=6); vagotomized, sinoaortic denervated, thoracic epidural morphine (n=5); or intravenous morphine (n=5). Mean arterial pressure (MAP), heart rate (HR), CSNA, and RSNA were measured 0, 15, 30, 60, 90, and 120 min after saline or morphine (200 microg/kg) administration and 15 min after reversal with 200 microg naloxone given intravenously. RESULTS: In the control group, no changes in measured variables were found after either thoracic epidural saline or intravenous naloxone. Thoracic and lumbar epidural morphine both significantly reduced MAP, HR, CSNA, and RSNA 30 through 120 min after morphine administration (P < 0.05). These changes were reversed by intravenous naloxone. Changes after thoracic epidural morphine administration in vagotomized, baroreceptor-denervated cats were similar to those in intact cats. Intravenous morphine produced no significant changes except for a decrease in MAP, which was reversed by intravenous naloxone. CONCLUSION: In contrast to intravenous morphine, thoracic and lumbar epidural morphine both inhibited cardiac and renal sympathetic nerve activity and consequently reduced MAP and HR in alpha-chloralose anesthetized cats.


Assuntos
Analgésicos Opioides/farmacologia , Anestésicos Intravenosos/farmacologia , Cloralose/farmacologia , Morfina/farmacologia , Sistema Nervoso Simpático/efeitos dos fármacos , Animais , Pressão Sanguínea/efeitos dos fármacos , Gatos , Coração/inervação , Frequência Cardíaca/efeitos dos fármacos , Rim/inervação
17.
Acta Anaesthesiol Scand ; 42(3): 358-68, 1998 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9542566

RESUMO

BACKGROUND: Platelet-activating factor (PAF), a lipid mediator released during endotoxin shock, induces pulmonary hypertension, systemic hypotension and cardiac dysfunction. In this study, we compared the effect of inhaled nitric oxide (NO) on PAF-induced pulmonary hypertension and NO metabolism with that on pulmonary hypertension induced by a stable thromboxane A2 mimetic, U46619. Since PAF-induced hypotension might be mediated by NO, the effect of inhaled NO combined with an intravenously administered NO synthase inhibitor, NG-nitro-L-arginine (L-NNA), on PAF-induced hemodynamic change was also investigated. METHODS: In a total of 28 beagles anesthetized with pentobarbital the following substances were intravenously administered: PAF 0.56 +/- 0.30 microgram.kg-1.min-1 (group PAF), L-NNA 10 mg.kg-1 + PAF 0.04 +/- 0.03 microgram.kg-1.min-1 (group L-NNA + PAF), U46619 0.60 +/- 0.11 microgram.kg-1.min-1 (group U46619) or L-NNA 10 mg.kg-1 + U46619 0.61 +/- 0.23 microgram.kg-1.min-1 (group L-NNA + U46619) to obtain a mean pulmonary arterial pressure (MPAP) of 25 mmHg. Nitric oxide was then inhaled at 5, 10, 20 and 40 ppm for 15 min at 15-min intervals in the order of increasing concentration. An additional 7 dogs (control group) inhaled NO at normal MPAP (17 mmHg). Hemodynamic and respiratory parameters, NOHb, NO2- + NO3-, and MetHb levels in blood were measured before and during NO administration. RESULTS: In the control group, hemodynamic and respiratory values did not change significantly during NO administration. In group PAF, NO significantly reversed the PAF-induced pulmonary hypertension. PAF induced a marked systemic hypotension and cardiac output reduction, but these changes were not affected by inhalation of NO. L-NNA pretreatment markedly decreased the dose of PAF required to maintain a MPAP of 25 mmHg, and abolished the PAF-induced hypotension. In group L-NNA + PAF, the diminishing effect of inhaled NO on pulmonary vascular resistance (PVR) was significantly greater than that in group PAF. U46619 induced pulmonary hypertension and increases in blood pressure, intrapulmonary shunt and peak airway pressure. L-NNA pretreatment did not change the dose of U46619 required to maintain a MPAP of 25 mmHg. The effects of inhaled NO on PVR decrease were similar in groups U46619 and L-NNA + U46619. No NOHb was detected in any group. NO2- + NO3- concentration increased during NO administrations. There were no significant differences in NO2- + NO3- concentration among groups. CONCLUSIONS: Inhaled NO at the dose of 5-40 ppm effectively reversed PAF-induced pulmonary hypertension, especially following pretreatment with L-NNA. Inhaled NO did not affect PAF-induced hypotension or cardiac dysfunction. These findings indicate that low concentrations of inhaled NO may be useful in reversing pulmonary hypertension in the endotoxemia where PAF may be one mediator.


Assuntos
Hipertensão Pulmonar/fisiopatologia , Óxido Nítrico/administração & dosagem , Fator de Ativação de Plaquetas , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico/farmacologia , Administração por Inalação , Animais , Cães , Relação Dose-Resposta a Droga , Hemodinâmica/efeitos dos fármacos , Hemoglobinas/análise , Hipertensão Pulmonar/sangue , Hipertensão Pulmonar/etiologia , Injeções Intravenosas , Metemoglobina/análise , Óxido Nítrico Sintase/antagonistas & inibidores , Nitroarginina/farmacologia , Oxigênio/sangue , Fator de Ativação de Plaquetas/fisiologia , Circulação Pulmonar/efeitos dos fármacos , Vasoconstritores
18.
Reg Anesth Pain Med ; 23(2): 147-51, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9570602

RESUMO

BACKGROUND AND OBJECTIVES: The visual analog scale (VAS) is a simple and sensitive mean of pain assessment. The faces scale is also a simple, self-reporting method for children. Facial signs of pain have not been used to assess pain in postoperative adult patients in the intensive care unit (ICU). METHODS: Fifty patients undergoing esophageal cancer surgery by a thoracoabdominal procedure were studied. Epidural opioids, such as morphine or buprenorphine, combined with bupivacaine were administered during and after surgery. Pain measurement was performed by a physician in the ICU using the self-reported VAS 0.5, 1, 2, 4, and 6 hours after tracheal extubation and thereafter every 4 hours during the stay in the ICU. A nurse who was unaware of the patients' VAS scores assessed facial expression as a measure of pain intensity using a five-grade faces scale immediately before pain evaluation by VAS. The VAS was rescaled into five discrete units that would match the five faces scale scores. Weighted kappa statistics were used to establish a relative level of agreement between the five-grade VAS and faces scale. RESULTS: Good agreement was found between the five-grade VAS and the faces scale 30 minutes and 1 hour after tracheal extubation (weighted kappa values .67 and .62, respectively). The VAS and faces scales were measured 7-13 times per patient during the stay in the ICU, and 518 observations were collected. Although moderate agreement was found between the five-graded VAS and faces scale for all pairs of observation (weighted kappa values .54), less agreement was found between them in patients with moderate pain. In addition, the calculated mean differences between the five-graded VAS and faces scale differed significantly between patients. CONCLUSION: The faces scale may be useful for pain evaluation in the ICU.


Assuntos
Observação , Medição da Dor/métodos , Dor Pós-Operatória/diagnóstico , Adulto , Neoplasias Esofágicas/cirurgia , Feminino , Humanos , Unidades de Terapia Intensiva , Masculino
20.
Ann Emerg Med ; 30(4): 507-12, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9326866

RESUMO

STUDY OBJECTIVE: To assess the treatment and outcome of patients with crush syndrome sustained in an earthquake disaster. METHODS: We conducted a retrospective analysis of eight patients with crush syndrome and subsequent acute kidney failure who were treated in the ICU of a university hospital. All eight patients had been extricated from buildings that collapsed in the 1995 Kobe, Japan, earthquake. Crush injury involved the upper extremities in one patient and the lower extremities in seven. Each patient received intravenous fluid infusion and diuretic drugs and underwent hemodialysis. Emergency fasciotomy was performed in some patients, 17 to 100 hours after extrication. RESULTS: All patients were conscious and lucid on admission, and blood pressure and heart rate were normal. All the patients demonstrated kidney failure with increased concentrations of serum creatinine (1.9 to 9.6 mg/dL [169 to 852 mumol/L]). Six patients were oliguric. Hyperkalemia (5.6 to 8.8 mEq/L) was present in six patients. We found close correlations between the serum potassium and creatine kinase concentrations, between the serum myoglobin and potassium concentrations, and between the serum myoglobin and creatine kinase concentrations. All the patients were weaned from hemodialysis. The serum creatinine concentration decreased to a normal level within 20 to 52 days of admission in all patients. No patients underwent amputation. Muscle weakness and sensory deficits persisted in all patients 6 months after the earthquake. CONCLUSION: Our findings support current therapeutic strategies for crush syndrome, despite the long delay to initiation of intensive therapy. All the patients recovered kidney function and were weaned from hemodialysis; none required amputation.


Assuntos
Síndrome de Esmagamento/fisiopatologia , Síndrome de Esmagamento/terapia , Desastres , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/terapia , Adulto , Idoso , Creatina Quinase/sangue , Creatinina/sangue , Síndrome de Esmagamento/etiologia , Diuréticos/uso terapêutico , Feminino , Hidratação , Humanos , Unidades de Terapia Intensiva , Japão , Masculino , Pessoa de Meia-Idade , Potássio/sangue , Diálise Renal , Estudos Retrospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...